Risk stratification of acute pulmonary embolism

Area of Science:

• Cardiology
• Pulmonary Medicine
• Critical Care Medicine

Background:

• Pulmonary embolism (PE) can present with severe hemodynamic compromise, necessitating urgent management.
• Risk stratification is vital for normotensive PE patients to predict hemodynamic collapse or bleeding risk.
• Current treatment options for high-risk PE lack definitive evidence-based recommendations.

Purpose of the Study:

• To review current approaches for risk stratification in pulmonary embolism.
• To highlight the importance of identifying patients at risk for hemodynamic collapse or major bleeding.
• To discuss the limitations in evidence for guiding treatment in high-risk PE.

Main Methods:

• Review of existing guidelines and risk stratification tools for pulmonary embolism.
• Analysis of physiological parameters, right heart dysfunction, and comorbidities for risk assessment.
• Evaluation of validated and emerging scores for predicting adverse outcomes in PE.

Main Results:

• Validated tools like ESC guidelines and Bova score aid in identifying normotensive PE patients at risk of collapse.
• Several scores (BACS, PE-CH, PE-SARD) are emerging to predict bleeding risk with different therapies.
• Low-risk PE patients can be safely managed as outpatients using tools like simplified PE Severity Index or Hestia criteria.

Conclusions:

• Accurate risk stratification is essential for tailoring PE management strategies.
• Further research is needed to establish optimal reperfusion therapies for high-risk PE.
• Outpatient management is feasible for selected low-risk PE patients, improving resource utilization.